Scinovex
article Open AccessTop 1% cited

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

The Journal of Experimental Medicine · 2006 · Vol. 203(7) · pp. 1693–1700
Nabila SeddikiBrigitte Santner‐NananJeff MartinsonJohn ZaundersSarah C. SassonAlan LandayMichael J. SolomonWarwick SelbyStephen I. AlexanderRalph NananAnthony D. KelleherBarbara Fazekas de St Groth

Abstract

Abnormalities in CD4(+)CD25(+)Foxp3(+) regulatory T (T reg) cells have been implicated in susceptibility to allergic, autoimmune, and immunoinflammatory conditions. However, phenotypic and functional assessment of human T reg cells has been hampered by difficulty in distinguishing between CD25-expressing activated and regulatory T cells. Here, we show that expression of CD127, the alpha chain of the interleukin-7 receptor, allows an unambiguous flow cytometry-based distinction to be made between CD127(lo) T reg cells and CD127(hi) conventional T cells within the CD25(+)CD45RO(+)RA(-) effector/memory and CD45RA(+)RO(-) naive compartments in peripheral blood and lymph node. In healthy volunteers, peripheral blood CD25(+)CD127(lo) cells comprised 6.35 +/- 0.26% of CD4(+) T cells, of which 2.05 +/- 0.14% expressed the naive subset marker CD45RA. Expression of FoxP3 protein and the CD127(lo) phenotype were highly correlated within the CD4(+)CD25(+) population. Moreover, both effector/memory and naive CD25(+)CD127(lo) cells manifested suppressive activity in vitro, whereas CD25(+)CD127(hi) cells did not. Cell surface expression of CD127 therefore allows accurate estimation of T reg cell numbers and isolation of pure populations for in vitro studies and should contribute to our understanding of regulatory abnormalities in immunopathic diseases.

T-cell and B-cell ImmunologyImmune Cell Function and InteractionImmunotherapy and Immune ResponsesIL-2 receptorInterleukin-7 receptorFOXP3Flow cytometryBiologyInterleukin 21ImmunologyPopulationCell biologyZAP70

MeSH terms

AdultHumansInfant, NewbornLymphocyte ActivationReceptors, Interleukin-2T-Lymphocyte SubsetsReceptors, Interleukin-7T-Lymphocytes, Regulatory

Funding

  • Crohn's and Colitis Foundation of America
  • Crohn's and Colitis Foundation
  • Medical Research Council
  • National Health and Medical Research Council
Citations
1,490
FWCI
39.48
field-weighted impact
References
30
Percentile
100%
vs. same field & year
Citations per year
Cited by
The PD‐1 pathway in tolerance and autoimmunity
Immunological Reviews · 2010 · 2,263 citations
Immunosenescence of ageing
The Journal of Pathology · 2007 · 832 citations
FOXP3+ regulatory T cells in the human immune system
Nature reviews. Immunology · 2010 · 2,398 citations
How regulatory T cells work
Nature reviews. Immunology · 2008 · 3,325 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.